In the current context of the COVID-19 pandemic, public health and access to it has (re)emerged as a major issue. In Vietnam, as anywhere else around the world, the pandemic has increased local demand
News
Pharmaceutical companies urged to invest in R&D, improve competitiveness
The Ministry of Health estimated the market at US$6.9 billion in 2021 while BMI Research forecast the market to reach $16.1 billion in 2026 with a compound growth rate of up to 11 per cent. HÀ
PHARMACEUTICAL INDUSTRY – GROWTH PROSPECTS FOR THE LAST 6 MONTHS OF 2022
In the past 2 years, Vietnam’s pharmaceutical industry has faced many difficulties due to supply chain disruptions, high prices of raw materials and transportation, along with tight regulations on
Vietnam Pharmaceutical Market Outlook To 2022
Vietnam Pharmaceutical market by Generic and Patented drugs, by Prescribed Drugs and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System,
Vietnam’s Growing Pharmaceutical Market
Vietnam’s pharmaceutical sector has grown significantly in the last decade with positive changes in government policies and an increase in domestic regulations of imported drugs. Regulations on
Vietnam’s pharmaceutical sector expected higher growth
Viet Nam’s pharmaceutical market is estimated to record revenue of US$5.2 billion in 2017, a 10 per cent increase from last year. The market is set for double digit growth within the next five years,
Vietnam – Healthcare
Overview Economic growth and demographic changes are driving demand for healthcare services throughout Vietnam, and not just in the two economic centers of Hanoi and Ho Chi Minh City. Public,
